Innovative Non-Invasive Tech Know Labs specializes in cutting-edge non-invasive medical diagnostics utilizing radiofrequency dielectric spectroscopy, creating opportunities to partner with healthcare providers, wellness brands, and telemedicine platforms seeking advanced symptom monitoring solutions.

Expansion in Blood Glucose Monitoring With the launch of their Generation 1 device targeting continuous blood glucose monitoring, there is significant potential to collaborate with diabetes care providers, medical device distributors, and pharmaceutical companies enhancing diabetes management tools.

Strategic Funding and Growth Recent $3.45M public offering and a total funding of $20M indicate strong investor confidence, enabling opportunities for partnerships with clinical research institutions and health tech investors looking to support innovative diagnostics.

Technology Collaborations Partnerships with entities like EdgeImpulse for machine learning enhancement point to opportunities in deploying AI-driven diagnostics, attracting software and healthcare analytics companies interested in integrating bio-RFID data into broader health platforms.

Emerging Market Presence As a publicly traded company on NYSE American with a small team, Know Labs is positioned for accelerated market entry and strategic alliances with distribution channels, wellness organizations, and health-focused companies looking to add non-invasive monitoring capabilities.